logo

Ionis Pharmaceuticals Inc (IONS)



Trade IONS now with
  Date
  Headline
5/18/2020 7:01:59 AM Akcea Therapeutics Names Michael Price EVP And CFO
4/20/2020 7:06:07 AM Ionis And Partner Announce Enrollment Completion Of Global Phase 3 GENERATION HD1 Study For Huntington's Disease
2/26/2020 7:21:56 AM Ionis Q4 EPS $1.28 Vs $2.21 Last Year
1/22/2020 7:09:37 AM Akcea And Ionis Announce Positive Topline Phase 2 Results Of AKCEA-APOCIII-L Rx
1/10/2020 7:02:55 AM Akcea And Ionis Begin CARDIO-TTRansform Phase 3 Clinical Trial For AKCEA-TTR-LRx
1/9/2020 7:06:20 AM Ionis Pharmaceuticals Appoints Onaiza Cadoret-Manier As Chief Corporate Development And Commercial Officer
12/19/2019 7:11:43 AM Ionis Licenses Investigational Alzheimer's Therapy; Earns $45 Mln License Fee
12/19/2019 7:05:00 AM Ionis licenses investigational Alzheimer's therapy (Press Release)
12/18/2019 7:09:20 AM Ionis Appoints Frank Bennett As Chief Scientific Officer And Eric Swayze SVP Of Research
12/12/2019 7:17:21 AM Ionis Pharma Announces Private Placement Of $507.5 Mln Of 0.125% Convertible Senior Notes Due 2024
11/6/2019 7:39:25 AM Ionis Pharmaceuticals Q3 Total Revenue $168 Mln Vs. $145 Mln Last Year
9/17/2019 10:30:52 PM Antisense Announces Positive Preliminary Results From ATL1102 For DMD Phase II Trial
8/27/2019 7:05:00 AM Ionis licenses hepatitis B program to GSK (Press Release)
8/7/2019 7:09:14 AM Ionis Pharma Q2 Net Loss Attributable To Common Stockholders $1 Mln Vs. Net Loss $40 Mln Last Year
7/1/2019 7:33:05 AM Biogen Announces New Results From NURTURE Study
6/12/2019 4:16:50 PM Ionis Appoints Joan Herman To Its Board Of Directors
5/9/2019 7:15:20 AM Ionis Pharmaceuticals Q1 Net Income $84 Mln Vs. Net Loss $1 Mln Last Year